Antibody deficiency is the most common class of immune deficiency in children and adults. Delayed diagnosis can result in preventable complications such as life-threatening bacterial infections and bronchiectasis. Where available, immunoglobulin replacement therapy is the treatment of choice for primary antibody deficiency syndromes to prevent recurrent infections and irreversible organ damage. Immunoglobulin replacement therapy has also been used to prevent infection in secondary immune deficiencies as well as to support bone marrow transplantation.
The Asia Pacific Immunoglobulins in Immunology Expert Group Inc (APIIEG) was formed to develop a consensus view on the use of immunoglobulin products in immune disorders in the region. The aim of the Consensus Recommendations for the Use of Immunoglobulin Replacement Therapy in Immune Deficiency is to support immunologists and other clinicians by providing practical advice on the use of immunoglobulin products in clinical practice.
This website contains a downloadable version of the consensus recommendations and contains the details of symposia and conventions where the group have, and are to present on the subject of immunoglobulins and their use in immune disorders.
Associate Professor Mimi Tang
Asia Pacific Immunoglobulins in Immunology Expert Group